This inventor holds 2 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1993-1994.
Company Filing History:
Years Active: 1993-1994
Title: The Innovative Contributions of Marc Herin
Introduction
Marc Herin is a notable inventor based in Montignies sur Sambre, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoporosis and pain management. With a total of 2 patents, Herin's work reflects a commitment to advancing medical science.
Latest Patents
Herin's latest patents include innovative methods for treating osteoporosis in mammals. One of his patents describes a method that involves administering a therapeutically-effective amount of a compound of Formula I. This compound is designed to provide effective treatment for osteoporosis. Another patent focuses on 2-, 3-, and 5- and/or 8-substituted dibenzoxazepine compounds, which are useful as analgesic agents for pain treatment. This patent outlines pharmaceutical compositions that combine these compounds with pharmaceutically-acceptable carriers, aiming to alleviate pain in animals.
Career Highlights
Marc Herin has had a distinguished career, working with G.D. Searle & Company, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to the development of new therapeutic options in the pharmaceutical industry.
Collaborations
Throughout his career, Herin has collaborated with esteemed colleagues such as Robert K. Husa and E. Ann Hallinan. These collaborations have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Marc Herin's contributions to the field of pharmaceuticals demonstrate his dedication to improving health outcomes through innovation. His patents reflect a deep understanding of medicinal chemistry and a commitment to addressing critical health issues.